Colin Gardner

Colin Gardner has a diverse and extensive work experience in the pharmaceutical and biotech industry. Colin co-founded Lyndra Therapeutics in 2015 and has been involved with the company since its inception. Prior to that, they worked as a Technical Consultant at Moderna and as a Senior Consultant at Entrega biosciences, both starting in 2010. Before that, they served as the President of Pharmavue LLC from 2009 onwards. Colin also co-founded Kala Pharmaceuticals in 2009 and was involved with the company until 2019. Colin Gardner held the position of CSO at Living Proof from 2012 to 2013. Colin was the SVP Research at Johnson and Johnson from 2005 to 2009. Prior to that, they served as the CSO at TransForm Pharmaceuticals from 2001 to 2005. Colin Gardner began their career at Merck & Co Inc in 1982, where they held the position of VP Pharmaceutical R&D until 2001. Colin started their professional journey as a Senior Scientist at Merrell International Research Center in 1975 and worked there until 1981.

Colin Gardner pursued their education in the field of Chemistry at the University of Glasgow, where they earned both a BSc and a PhD degree. Their educational journey at the University of Glasgow spanned from 1962 to 1970.